Plain-English translation of NCT06635564 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing three different devices — ClotPro, ROTEM delta, and TEG 6s — that measure how quickly and effectively your blood clots. These devices help doctors decide whether you need blood products or medications to prevent bleeding during major surgery. The study wants to find out which device gives the fastest results and most accurate information to help doctors personalize your care during liver surgery, brain surgery, or cesarean delivery.
During major surgery, doctors currently use blood clotting tests to guide treatment decisions, but they're not sure which device works best or whether the results are truly predictive of bleeding complications. This trial aims to establish clearer guidelines for using this technology to reduce unnecessary blood transfusions and prevent serious bleeding problems.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be asked to provide informed consent before your surgery. During your operation, doctors will use all three blood clotting devices to test your blood and compare their results. You won't need extra visits beyond your scheduled surgery — the testing happens as part of your routine surgical care. Researchers will track whether you have any bleeding problems or blood clots after surgery to see if the test results predicted these outcomes.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Austria